121
Views
46
CrossRef citations to date
0
Altmetric
Original Research

Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis

, , , , , , , , & show all
Pages 2051-2064 | Published online: 04 Apr 2018

References

  • FeldmannMBrennanFMMainiRNRole of cytokines in rheumatoid arthritisAnnu Rev Immunol19961413974408717520
  • SmolenJSAletahaDMcInnesIBRheumatoid arthritisLancet2016388100552023203827156434
  • MokCCTsaiWCChenDYWeiJCImmunogenicity of anti-TNF biologic agents in the treatment of rheumatoid arthritisExpert Opin Biol Ther201616220121126560845
  • EdgintonSHitchonCFroeseWEl-GabalawyHEffects of rituximab and infliximab treatment on carboxypeptidase b and its substrates in RA synoviumJ Rheumatol201643584685426932340
  • HereniusMMOliveiraASWijbrandtsCAGerlagDMTakPPLebreMCAnti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammationPLoS One201382e5780223460910
  • Fanet-GoguetMMartinSFernandezCFautrelBBourgeoisPLe point sur les biothérapies dans la polyarthrite rhumatoïde: principes actifs disponibles, stratégie thérapeutique [Focus on biological agents in rheumatoid arthritis: newer treatments and therapeutic strategies]Therapie2004594451461 French [with English abstract]15559549
  • GravalleseEMWalshNCRheumatoid arthritis: repair of erosion in RA – shifting the balance to formationNat Rev Rheumatol201171162662821931342
  • Goldbach-ManskyRWilsonMFleischmannRComparison of Tripterygium wilfordii Hook F. versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trialAnn Intern Med20091514229240W49W5119687490
  • O’DellJRTherapeutic strategies for rheumatoid arthritisN Engl J Med2004350252591260215201416
  • KaldenJREmerging therapies for rheumatoid arthritisRheumatol Ther201631314227747522
  • LandeweRBvan der HeijdeDComment on: ‘comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial’ by Qian-wen et alAnn Rheum Dis20147310e6225013090
  • GrazioseRLilaMARaskinIMerging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foodsCurr Drug Discov Technol20107121220156139
  • CameronMGagnierJJLittleCVParsonsTJBlumleAChrubasikSEvidence of effectiveness of herbal medicinal products in the treatment of arthritis. Part 2: rheumatoid arthritisPhytother Res200923121647166219941324
  • KupchanSMCourtWADaileyRGGilmoreCJBryanRFTriptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordiiJ Am Chem Soc19729420719471955072337
  • LuYZhangYLiLTAB1: a target of triptolide in macrophagesChem Biol201421224625624462677
  • MattaRWangXGeHRayWNelinLDLiuYTriptolide induces anti-inflammatory cellular responsesAm J Transl Res20091326728219956437
  • ZhangYMaXTriptolide inhibits IL-12/IL-23 expression in APCs via CCAAT/enhancer-binding protein alphaJ Immunol201018473866387720194724
  • LiJShenFGuanCActivation of Nrf2 protects against triptolide-induced hepatotoxicityPLoS One201497e10068524988078
  • QuanLZhangYCrielaardBJNanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomesACS Nano20148145846624341611
  • MeiZLiXWuQHuSYangXThe research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticlePharmacol Res200551434535115683748
  • RamasamyTHaidarZSTranTHLayer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugsActa Biomater201410125116512725169256
  • RamasamyTRuttalaHBGuptaBSmart chemistry-based nano-sized drug delivery systems for systemic applications: a comprehensive reviewJ Control Release201725822625328472638
  • RamasamyTRuttalaHBChitrapriyaNEngineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumorsActa Biomater20174813114327794477
  • SundaramoorthyPRamasamyTMishraSKEngineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cellsActa Biomater20164222023127395829
  • RamasamyTRuttalaHBChoiJYEngineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecanChem Commun2015512657585761
  • FengZLaiYYeHHuangJXiXGWuZPoly (gamma, L-glutamic acid)-cisplatin bioconjugate exhibits potent antitumor activity with low toxicity: a comparative study with clinically used platinum derivativesCancer Sci2010101112476248220813014
  • GengXYeHFengZSynthesis and characterization of cisplatin-loaded, EGFR-targeted biopolymer and in vitro evaluation for targeted deliveryJ Biomed Mater Res Part A20121001028392848
  • XiongYJiangWShenYA poly(γ, l-glutamic acid)-citric acid based nanoconjugate for cisplatin deliveryBiomaterials201233297182719322795851
  • ZhangLGengXZhouJFabrication of poly(gamma-glutamic acid)-based biopolymer as the targeted drug delivery system with enhanced cytotoxicity to APN/CD13 over-expressed cellsJ Drug Target201523545346125648136
  • MatsuoKKoizumiHAkashiMIntranasal immunization with poly(gamma-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunityJ Control Release2011152231031621402114
  • YoshikawaTOkadaNOdaANanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cellsVaccine200826101303131318255205
  • GengYLinDShaoLYanFJuHCellular delivery of quantum dot-bound hybridization probe for detection of intracellular pre-microRNA using chitosan/poly(gamma-glutamic acid) complex as a carrierPLoS One201386e6554023762388
  • YamaguchiSTatsumiTTakeharaTEphA2-derived peptide vaccine with amphiphilic poly(gamma-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumorCancer Immunol Immunother201059575976719943047
  • KulhariHTelukutlaSRPoojaDPeptide grafted and self-assembled poly(gamma-glutamic acid)-phenylalanine nanoparticles targeting camptothecin to gliomaNanomedicine (Lond)201712141661167428635550
  • SunCXuSGuoJXuKWangCThe inhibitory and apoptotic effects of docetaxel-loaded mesoporous magnetic colloidal nanocrystal clusters on bladder cancer T24 cells in vitroJ Biomed Nanotechnol201410345546224730241
  • ZhangLWangTLiQFabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivoInt J Nanomedicine2016112663267327354796
  • KefferJProbertLCazlarisHTransgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritisEMBO J19911013402540311721867
  • LiPSchwarzEMThe TNF-alpha transgenic mouse model of inflammatory arthritisSpringer Semin Immunopathol2003251193312904889
  • LiangQJuYChenYLymphatic endothelial cells efferent to inflamed joints produce iNOS and inhibit lymphatic vessel contraction and drainage in TNF-induced arthritis in miceArthritis Res Ther2016186226970913
  • KimTLeeWBaekSHEffects of alveolar bone displacement with segmental osteotomy: micro-CT and histomorphometric analysis in ratsBraz Oral Research2016301e132
  • ArforsKERutiliGSvensjoEMicrovascular transport of macromolecules in normal and inflammatory conditionsActa Physiol Scand Suppl197946393103382749
  • MishraPRAl ShaalLMullerRHKeckCMProduction and characterization of Hesperetin nanosuspensions for dermal deliveryInt J Pharm20093711–218218919162147
  • BhattacharjeeSDLS and zeta potential – what they are and what they are not?J Control Release201623533735127297779
  • PatilSLisLGSchumacherRJPhosphonooxymethyl prodrug of triptolide: synthesis, physicochemical characterization, and efficacy in human colon adenocarcinoma and ovarian cancer xenograftsJ Med Chem201558239334934426596892
  • SharmaRWendtJARasmussenJCAdamsKEMarshallMVSevick-MuracaEMNew horizons for imaging lymphatic functionAnn N Y Acad Sci20081131133618519956
  • WeisslederRA clearer vision for in vivo imagingNat Biotechnol200119431631711283581
  • Sevick-MuracaEMSharmaRRasmussenJCImaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility studyRadiology2008246373474118223125
  • MassoudTFGambhirSSMolecular imaging in living subjects: seeing fundamental biological processes in a new lightGenes Dev200317554558012629038
  • SanoKNakajimaTMiyazakiKShort PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probesBioconjug Chem201324581181623600922
  • HayerSRedlichKKorbAHermannSSmolenJSchettGTenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritisArthritis Rheum2007561798817195210
  • McinnesIBSchettGCytokines in the pathogenesis of rheumatoid arthritisNat Rev Immunol20077642944217525752
  • DiamantopoulosAFinckhAHuizingaTTocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UKPharmacoeconomics201432877578724854959
  • ChenCYuCHChengYCYuPHFCheungMKPreparation and characterization of biodegradable nanoparticles based on amphiphilic poly(3-hydroxybutyrate)–poly(ethylene glycol)–poly(3-hydroxybutyrate) triblock copolymerEur Polym J2006421022112220
  • ShimaFAkagiTAkashiMEffect of hydrophobic side chains in the induction of immune responses by nanoparticle adjuvants consisting of amphiphilic poly(gamma-glutamic acid)Bioconjug Chem201526589089825865284
  • YanXTongZChenYBioresponsive materials for drug delivery based on carboxymethyl chitosan/poly(gamma-glutamic acid) composite microparticlesMar Drugs2017155 pii: E127
  • GongXChenYWuYAbsorption and metabolism characteristics of triptolide as determined by a sensitive and reliable LC-MS/MS methodMolecules20152058928894025993421
  • ChoyEHPanayiGSCytokine pathways and joint inflammation in rheumatoid arthritisN Engl J Med20013441290791611259725
  • AlexopoulouLPasparakisMKolliasGA murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signalingEur J Immunol19972710258825929368614
  • BoutaEMKuzinIde Mesy BentleyKBrief report: treatment of tumor necrosis factor-transgenic mice with anti-tumor necrosis factor restores lymphatic contractions, repairs lymphatic vessels, and may increase monocyte/macrophage egressArthritis Rheumatol20176961187119328118521